Enzymatic synthesis method of disialic acid-milk-N-tetrasaccharide
By using a multi-enzyme strategy to synthesize natural DSLNT from lactose in the Pichia cerevisiae expression system, the complex problems of sialic acid glycosyltransferase expression restriction and traditional synthesis methods in the prior art were solved, and efficient and simple DSLNT synthesis was achieved. Its clinical application lays the material foundation.
Patent Information
- Application Number
- CN202411208902.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-11-29
AI Technical Summary
The prior art is difficult to efficiently synthesize natural disialic acid-lact-N-tetrasaccharide (DSLNT). Due to the inability to express sialic acid glycosyltransferase in large quantities, the enzymatic synthesis of DSLNT is restricted, and the traditional fermentation method is complex in the components and requires complex separation. Purification, chemical synthesis is cumbersome and difficult to achieve scale.
Using the 'one pot multi-enzyme' strategy, β1,3-N-acetylglucosamine transferase, galactosyltransferase, sialic acid glycosyltransferase and amino group were used in four steps from the lactose starting product. Glucosyl sialic acid glycosyl transferase at 6 was obtained by the Pichia ceramic acid glycosyl transferase at 6 by the Pichia ceramic acid glycosyl sialic acid glycosyl transferase at 6, and natural DSLNT was successfully synthesized.
A total yield of 67% was achieved, complex protection/deprotection operations were avoided, the synthesis steps were simple, easy to purify, and high efficiency. It was suitable for the large-scale preparation of DSLNT, laying a material foundation for its mechanism of action and clinical treatment research.
Smart Images

Figure CN119040414A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of polysaccharide synthesis, and specifically relates to an enzymatic synthesis method of disialyl-lacto-N-tetraose. Background Art
[0002] Necrotizing enterocolitis (NEC) is a serious intestinal disease that mainly occurs in premature infants. The incidence rate in extremely low-birth-weight premature infants (weighing less than 1500g) is 15%, and the mortality rate is as high as 30%. It is the main cause of death in the neonatal intensive care unit. Studies have found that the rate of NEC in formula-fed newborns is 10 times that of breast-fed infants. In 2017, Professor Bode revealed through clinical data that human milk oligosaccharide disialyl-lacto-N-tetraose (DSLNT) can improve intestinal health by regulating neonatal intestinal microorganisms and effectively prevent necrotizing enterocolitis in children. Although DSLNT has been found to have a good effect on preventing necrotizing enterocolitis, due to the inability to obtain sufficient amounts of natural DSLNT, research on its mechanism of action and clinical therapeutic effects cannot be carried out systematically.
[0003] Natural DSLNT is a hexasaccharide compound with the following structure:
[0004]
[0005] Theoretically, there are four main ways to prepare DSLNT: breast milk extraction, fermentation preparation, chemical synthesis, and enzymatic synthesis.
[0006] DSLNT is derived from breast milk, which has a limited source and a complex composition. Therefore, it is extremely difficult to obtain sufficient samples with a single structure by relying solely on natural extraction.
[0007] The preparation of polysaccharides by fermentation is to produce a large amount of target compounds by fermentation with genetically modified bacterial strains, and then obtain polysaccharide samples with a defined structure through continuous and complex separation and purification methods. Invention patent CN 118215741 A describes a method for recombinant production of human milk polysaccharides by an improved seed fermentation process, and further applies this method to the synthesis of DSLNT. This improved process can improve the production efficiency of traditional fermentation methods, but the overall fermentation efficiency is still not high, and the ingredients are complex, requiring complex separation and purification to obtain the target product with a defined structure.
[0008] Chemical synthesis of polysaccharides requires cumbersome functional group protection / deprotection operations, and each step requires separation and purification. In addition, it is extremely difficult to construct a single-configuration glycosidic bond, making it difficult to achieve large-scale amplification. So far, there has been no report on the chemical synthesis of natural DSLNT, and only the synthesis of the precursor lactoyl-N-tetraose (LNT) and DSLNT derivatives has been reported. After the synthesis of all monosaccharide modules, the Schmidt R. research group used trichloroacetimidyl as the leaving group, and synthesized fully protected lactoyl-N-tetraose (LNT) with a total yield of 28% in 5 steps. Based on the synthesis of monosaccharide modules, the Wong CH research group synthesized deprotected lactoyl-N-tetraose (LNT) with a total yield of 21% in 5 steps. The Ando T. research group started with the prepared trisaccharides (lactose and glucosamine) and obtained DSLNT derivatives with 17% and 28% respectively through two synthetic routes. However, regardless of the route, a large amount of β-glycosidic bond products will be formed during the sialic acid glycosylation process, which will reduce the yield and increase the difficulty of separation and purification.
[0009] Enzymatic synthesis avoids complex protection / deprotection operations, has simple synthesis steps, can obtain a single-configuration glycosidic bond, and has a high yield. However, the 6th position of glucosamine in DSLNT is connected to sialic acid, and sialylglycosyltransferase (ST6GlcNAc-I) is isolated from mammals and cannot be expressed in large quantities in microbial expression systems, which limits the enzymatic synthesis of DSLNT. Professor Xi Chen's research group at the University of California used the existing microbial-derived sialyltransferase expression system to synthesize a series of DSLNT analogs, among which the most active compounds were DS'LNT and DSLNnT, with an activity of about one-tenth that of DSLNT.
[0010] In summary, up to now, there is only one report on the preparation of natural DSLNT by fermentation. However, the fermentation method has complex components and requires complex separation and purification. The efficient enzymatic synthesis of DSLNT has not been reported so far due to the inability to express sialylglycosyltransferase (ST6GALNAC-6) in large quantities. Summary of the invention
[0011] In view of the shortcomings of the prior art, the purpose of the present invention is to provide an enzymatic synthesis method of disialyl-lacto-N-tetraose. The present invention uses lactose as a starting material, adopts a "one-pot multi-enzyme" strategy, and synthesizes natural DSLNT through four steps, laying a material foundation for the study of its mechanism of action and clinical therapeutic effects.
[0012] To achieve the above technical objectives, the technical solution adopted by the present invention is: an enzymatic synthesis method of disialyl-lacto-N-tetraose, using lactose as a starting material, sequentially using β1,3-N-acetylglucosamine transferase, galactosyltransferase, position 3 sialylglycosyltransferase and aminoglucose position 6 sialylglycosyltransferase to sequentially assemble N-acetylglucosamine, galactose and two sialic acid monosaccharide modules to obtain natural disialyl-lacto-N-tetraose; the synthetic route is:
[0013]
[0015] Preferably, the synthesis method of trisaccharide compound 2 is as follows: lactose 1 is used as an acceptor, the reaction system comprises 1.0-3.0 equivalents of N-acetylglucosamine, 1.0-3.0 equivalents of adenosine triphosphate, 1.0-3.0 equivalents of uridine triphosphate, pH 5.0-10.0 Tris-HCl buffer and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then N-acetylhexosamine-kinase / sugar nucleoside generating enzyme and β1,3-N-acetylglucosamine transferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-72 hours, and after the reaction is completed, the trisaccharide compound 2 is purified.
[0016] Preferably, the synthesis method of tetrasaccharide compound 3 is as follows: trisaccharide compound 2 is a receptor, the reaction system comprises 1.0-3.0 equivalents of galactose, 1.0-3.0 equivalents of adenosine triphosphate, 1.0-3.0 equivalents of uridine triphosphate, pH 5.0-10.0 Tris-HCl buffer and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then galactokinase, UDP-sugar pyrophosphorylase and galactosyltransferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-72 hours, and after the reaction is completed, the tetrasaccharide compound 3 is purified.
[0017] Preferably, the synthesis method of pentasaccharide compound 4 is as follows: tetrasaccharide compound 3 is a receptor, the reaction system comprises 1.0-3.0 equivalents of sialic acid, 1.0-3.0 equivalents of adenosine triphosphate, pH 5.0-10.0 Tris-HCl buffer and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then CMP-sialic acid synthetase and position 3 sialylglycosyltransferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-24 hours, and after the reaction is completed, the pentasaccharide compound 4 is purified to obtain.
[0018] Preferably, the synthesis method of hexasaccharide compound 5 is as follows: pentasaccharide compound 4 is used as the receptor, the reaction system comprises 1.0-3.0 equivalents of sialic acid, 1.0-3.0 equivalents of adenosine triphosphate, Tris-HCl buffer with a pH of 5.0-10.0 and 5-100 mmol of magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then CMP-sialic acid synthetase and aminoglucose 6-sialyltransferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-24 hours, and after the reaction is completed, the hexasaccharide compound 5 is purified to obtain.
[0019] Preferably, the aminoglucose 6-sialyltransferase (ST6GALNAC6) is obtained by constructing a recombinant expression system; the recombinant expression system is a non-microbial expression system.
[0020] Preferably, in the synthesis of tetrasaccharide compounds 3 to hexasaccharide compounds 5, thin layer chromatography is used to track the reaction progress after the reaction is completed, and the developing solvent is ethyl acetate: methanol: water: acetic acid = 4:2:1:0.2 system for detection.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] 1. The present invention proposes an enzymatic synthesis method of human milk oligosaccharide: disialyl-lacto-N-tetraose (DSLNT). By using the constructed Pichia pastoris expression system to obtain aminoglucose position 6 sialyltransferase (ST6GALNAC6) and the glycosyltransferase (HpLgtA), galactosyltransferase (Cvβ3GalT), and position 3 sialyltransferase (PmST1 M144D) obtained by the microbial expression system, the natural human milk oligosaccharide DSLNT was successfully synthesized for the first time, laying a material foundation for its subsequent mechanism of action and clinical effect research.
[0023] 2. Compared with traditional animal milk extraction, fermentation preparation and complex and lengthy chemical synthesis methods, the present invention gives full play to the high efficiency and high regional selectivity of enzymatic synthesis. Starting from lactose, the four-step enzymatic cascade reaction can achieve the synthesis of natural DSLNT with a total yield of 67%; and avoids the use of expensive nucleoside activated glycosyl donors. The synthesis steps are simple, easy to purify, and highly efficient, making it easier to achieve large-scale preparation of DSLNT. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 is the tetrasaccharide LNT synthesized in the embodiment of the present invention 1 H spectrum;
[0025] Figure 2 is the tetrasaccharide LNT synthesized in the embodiment of the present invention 13 C spectrum;
[0026] Figure 3 The pentasaccharide LSTa synthesized in the embodiment of the present invention is 1 H spectrum;
[0027] Figure 4 The pentasaccharide LSTa synthesized in the embodiment of the present invention is 13 C spectrum;
[0028] Figure 5 is the hexasaccharide DSLNT synthesized in the embodiment of the present invention 1 H spectrum;
[0029] Figure 6 is the hexasaccharide DSLNT synthesized in the embodiment of the present invention 13 C spectrum. DETAILED DESCRIPTION
[0030] In order to fully illustrate the preparation concept of the present invention, the process of this scheme is described below in conjunction with a specific implementation example; the compound structure is characterized by nuclear magnetic hydrogen spectrum and carbon spectrum.
[0031] Glucosamine 6-position sialyltransferase (ST6GALNAC6) is derived from mammals and cannot be constructed in a microbial expression system. In contrast, the Pichia pastoris expression system has obvious advantages in terms of processing, exo-secretion, post-translational modification, and glycosylation modification of the expression product, and has low culture costs and high expression levels. To this end, the present invention uses the Pichia pastoris expression system to recombinantly express human ST6GALNAC6 to obtain ST6GALNAC6 with enzyme activity.
[0032] The specific construction process is as follows: search NCBI to find the full-length gene sequence (CDS region) of ST6GALNAC6 (Gene ID: 30815; NCBI Reference Sequence: NM_013443.5), synthesize the full-length gene sequence of ST6GALNAC6, and clone its full-length coding region into the secretory yeast expression vector pPIC9K, construct a recombinant vector, and electroporate it into Pichia pastoris GS115 for expression to obtain a recombinant strain that can secrete and express ST6GALNAC6, and use Sephadex G-100 to purify to obtain high-purity glucosamine 6-position sialyltransferase.
[0033] The other three glycosyltransferases HpLgtA, Cvβ3GalT, and PmST1 M144D can all be obtained using the constructed microbial expression system.
[0034] Other enzymes used in the synthesis process of the present invention include N-acetylhexosamine-kinase / sugar nucleoside generator (NahK / GlmU), galactokinase (GalK), UDP-sugar pyrophosphorylase (BLUSP), CMP-sialic acid synthetase (NmCSS).
[0035] The enzymatic synthesis method of disialyl-lacto-N-tetraose provided by the present invention has the following synthesis route:
[0036]
[0037] 1. Synthesis of trisaccharide compound 2 [GlcNAcβ1,3Galβ1,4Glc]:
[0038] The synthesis method of the trisaccharide compound 2 of the present invention is as follows: lactose receptor compound 1 (80 mg), N-acetylglucosamine (1.5 equivalents, 63 mg), adenosine triphosphate (ATP, 2.0 equivalents, 178 mg), uridine triphosphate (UTP, 2.0 equivalents, 226 mg), Tris-HCl buffer (100 mM, pH 8.0) and magnesium chloride (20 mM) are dissolved in a 50 mL centrifuge tube, NahK / GlmU (1.0-3.0 mg) and HpLgtA (2.0-5.0 mg) are added, and after adding double distilled water to a total volume of 10 mL, the reaction system is placed in a shaker and incubated at 37° C. and 120 r / min for 12 hours. After the reaction is completed by thin layer chromatography (ethyl acetate: methanol: water: acetic acid = 4:2:1:0.2), anhydrous ethanol is added in an equal volume to the reaction system, and the reaction is allowed to stand at 4° C. for 30 minutes to terminate the reaction. The reaction system was centrifuged at 4° C. and 11000 r / min for 20 minutes, and the supernatant was collected and concentrated by rotary evaporation. The white compound 2 (115 mg, 90%) was obtained by separation by Bio-Gel P2 gel molecular exclusion chromatography.
[0039] 2. Synthesis of tetrasaccharide compound 3 [Galβ1,4GlcNAcβ1,3Galβ1,4Glc]:
[0040] The synthesis method of the tetrasaccharide compound 3 of the present invention is as follows: the trisaccharide compound 2 (80 mg), galactose (1.5 equivalents, 40 mg), adenosine triphosphate (ATP, 2.0 equivalents, 112 mg), uridine triphosphate (UTP, 2.0 equivalents, 142 mg), Tris-HCl buffer (100 mM, pH 7.5) and magnesium chloride (20 mM) are dissolved in a 50 mL centrifuge tube, GalK (1.0-3.0 mg), BLUSP (1.0-3.0 mg) and Cvβ3GalT (2.0-5.0 mg) are added, and double distilled water is added to a total volume of 10 mL, and the reaction system is placed in a shaker and incubated at 37° C. and 120 r / min for 12 hours. After the reaction is completed by thin layer chromatography (ethyl acetate: methanol: water: acetic acid = 4:2:1:0.2), anhydrous ethanol is added in an equal volume to the reaction system, and the reaction is allowed to stand at 4° C. for 30 minutes to terminate the reaction. The reaction system was centrifuged at 4° C. and 11000 r / min for 20 minutes, and the supernatant was collected and concentrated by rotary evaporation. The white compound 3 (94 mg, 91%) was obtained by separation by Bio-Gel P2 gel molecular exclusion chromatography.
[0041] 1 H spectrum Figure 1 As shown, 1 H NMR(400MHz,D2O)δ5.20(d,J=3.7Hz,1H),4.71(d,J=8.3Hz,1H),4.64(d,J=8.0Hz,1H),4.42(d,J=7.7 Hz, 2H), 4.13 (d, J = 3.1Hz, 1H), 3.95–3.66 (m, 16H), 3.65–3.43 (m, 8H), 3.29–3.22 (m, 1H), 2.01 (s, 3H).
[0042] 13 C spectrum Figure 2 As shown, 13 C NMR(101MHz,D2O)δ174.96,103.46,102.89,102.54,95.71,91.78,82.02,81.96,78.36,78.25,75.25,75.15,74.87,74.77,74 .32,73.76,72.43,71.37,71.10,70.65,70.09,69.98,68.51,68.42,68.29,61.01,60.94,60.47,60.05,59.92,54.67,22.21.
[0043] 3. Synthesis of pentasaccharide compound 4 [Neu5Acα2,3Galβ1,4GlcNAcβ1,3Galβ1,4Glc]:
[0044] The synthesis method of the pentasaccharide compound 4 of the present invention is as follows: tetrasaccharide compound 3 (80 mg), sialic acid (Neu5Ac, 1.2 equivalents, 42 mg), cytidine triphosphate (CTP, 1.5 equivalents, 82 mg), Tris-HCl buffer (100 mM, pH 8.0) and MgCl2 (20 mM) are dissolved in a 50 mL centrifuge tube, NmCSS (1.0-3.0 mg) and PmST1M144D (2.0-3.0 mg) are added, and after adding double distilled water to a total volume of 10 mL, the reaction system is placed in a shaker and incubated at 37° C. and 120 r / min for 3 hours. After the reaction is completed by thin layer chromatography (ethyl acetate: methanol: water: acetic acid = 4:2:1:0.2), anhydrous ethanol is added in an equal volume to the reaction system, and the reaction is allowed to stand at 4° C. for 30 minutes to terminate the reaction. The reaction system was then centrifuged at 4° C. and 11000 r / min for 20 minutes, the supernatant was collected, concentrated by rotary evaporation, and separated by Bio-Gel P2 gel molecular exclusion chromatography to obtain white compound 4 (105 mg, 93%).
[0045] 1 H spectrum Figure 3 As shown, 1 H NMR (400MHz, D2O) δ5.21(d,J=3.7Hz,1H),4.72(d,J=8.4Hz,1H),4.65(d,J=8.0Hz,1H),4.49(d,J=7.8Hz,1H),4.42(d,J=7.8Hz,1H),4.13( d,J=3.1Hz,1H),4.07(dd,J=9.8,3.0Hz,1H),3.99–3.36(m,27H),3.30–3.20(m,1H),2.74(dd,J=12.4,4.5Hz,1H),1.77(t,J=12.1Hz,1H).
[0046] 13 C spectrum Figure 4 As shown, 13C NMR(151MHz,D2O)δ175.09,175.00,173.97,103.46,103.01,102.99,102.57,99.77 ,95.84,91.91,82.27,82.03,78.57,78.45,75.70,75.31,75.18,74.99,74.89,74. 45,73.90,72.90,71.93,71.50,71.23,70.22,70.11,69.19,68.58,68.45,68.15,67.38,62.58,61.12,61.07,60.64,60.20,60.07,54.69,51.78,39.87,22.43,22.18.
[0047] 4. Synthesis of hexasaccharide compound 5 [Neu5Acα2,3Galβ1,4(Neu5Acα2,6)GlcNAcβ1,3Galβ1,4Glc]:
[0048] The synthesis method of the hexasaccharide compound 5 of the present invention is as follows: pentasaccharide compound 4 (80 mg), sialic acid (Neu5Ac, 1.2 equivalents, 30 mg), cytidine triphosphate (CTP, 1.5 equivalents, 58 mg), Tris-HCl buffer (100 mM, pH 8.0) and MgCl2 (20 mM) are dissolved in a 50 mL centrifuge tube, NmCSS (1.0-3.0 mg) and ST6GALNAC6 (3.0-6.0 mg) are added, and double distilled water is added to a total volume of 10 mL, and the reaction system is placed in a shaker and incubated at 37° C. and 120 r / min for 3 hours. After the reaction is completed by thin layer chromatography (ethyl acetate: methanol: water: acetic acid = 3:2:1:0.2), anhydrous ethanol is added in an equal volume to the reaction system, and the reaction is allowed to stand at 4° C. for 30 minutes to terminate the reaction. The reaction system was then centrifuged at 4° C. and 11000 r / min for 20 minutes, the supernatant was collected, concentrated by rotary evaporation, and separated by Bio-Gel P2 gel molecular exclusion chromatography to obtain white compound 5 (92 mg, 89%).
[0049] 1 H spectrum Figure 5 As shown, 1H NMR (400MHz, D2O) δ5.13(s,1H),4.61(d,J=7.6Hz,1H),4.57(d,J=7.9Hz,1H),4.41(d,J=7.5Hz,1H),4.34(d,J=7.5Hz,1H),4.08( s,3H),3.99(d,J=9.6Hz,1H),3.91–3.40(m,34H),3.19(s,1H),2.72–2.61(m,2H),1.69(t,J=11.8Hz,1H),1.60(t,J=12.2Hz,1H).
[0050] 13 C spectrum Figure 6 As shown, 13 C NMR(151MHz,D2O)δ175.08,174.91,173.96,173.49,103.47,102.97,102.61,100.26,99.69,95.79,91.8 6,82.32,82.29,81.88,78.55,78.44,75.66,75.13,75.05,74.86,74.42,73.82,73.79,72.84,72.56,71. 88,71.75,71.46,71.17,70.17,70.04,70.02,69.16,68.49,68.45,68.39,68.29,68.24,68.21,68.10,67.33,62.93,62.64,62.50,61.17,61.10,60.14,60.00,54.67,51.91,51.71,40.13,39.83,22.37,22.09.
Claims
1. An enzymatic synthesis method of disialyl-lacto-N-tetraose, characterized in that: Using lactose as the starting material, β1,3-N-acetylglucosamine transferase, galactosyltransferase, sialyltransferase at position 3 and sialyltransferase at position 6 of glucosamine are used to assemble N-acetylglucosamine, galactose and two sialic acid monosaccharide modules in sequence to obtain natural disialyl-lacto-N-tetraose; the synthetic route is:
2. The enzymatic synthesis method according to claim 1, characterized in that The synthesis method of trisaccharide compound 2 is as follows: lactose 1 is used as an acceptor, the reaction system comprises 1.0-3.0 equivalents of N-acetylglucosamine, 1.0-3.0 equivalents of adenosine triphosphate, 1.0-3.0 equivalents of uridine triphosphate, pH 5.0-10.0 Tris-HCl buffer and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, then N-acetylhexosamine-kinase / sugar nucleoside generating enzyme and β1,3-N-acetylglucosamine transferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-72 hours, and after the reaction is completed, the trisaccharide compound 2 is purified.
3. The enzymatic synthesis method according to claim 1, characterized in that The synthesis method of tetrasaccharide compound 3 is as follows: trisaccharide compound 2 is used as a receptor, the reaction system comprises 1.0-3.0 equivalents of galactose, 1.0-3.0 equivalents of adenosine triphosphate, 1.0-3.0 equivalents of uridine triphosphate, pH 5.0-10.0 Tris-HCl buffer and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then recombinant galactokinase, UDP-sugar pyrophosphorylase and galactosyltransferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-72 hours, and after the reaction is completed, the tetrasaccharide compound 3 is purified.
4. The enzymatic synthesis method according to claim 1, characterized in that The synthesis method of pentasaccharide compound 4 is as follows: tetrasaccharide compound 3 is used as a receptor, the reaction system contains 1.0-3.0 equivalents of sialic acid, 1.0-3.0 equivalents of adenosine triphosphate, pH 5.0-10.0 Tris-HCl buffer and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then CMP-sialic acid synthetase and position 3 sialylglycosyltransferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-24 hours, and after the reaction is completed, the pentasaccharide compound 4 is purified to obtain.
5. The enzymatic synthesis method according to claim 1, characterized in that The synthesis method of hexasaccharide compound 5 is as follows: pentasaccharide compound 4 is used as a receptor, the reaction system contains 1.0-3.0 equivalents of sialic acid, 1.0-3.0 equivalents of adenosine triphosphate, Tris-HCl buffer with a pH of 5.0-10.0 and 5-100 mmol magnesium chloride, the pH of the reaction system is adjusted to 4.5-8.5, and then CMP-sialic acid synthetase and aminoglucose 6-sialyltransferase are added, the reaction system is placed in a shaker, 37°C, 0-240 r / min, the reaction time is 3-24 hours, and after the reaction is completed, the hexasaccharide compound 5 is purified to obtain.
6. The enzymatic synthesis method according to claim 1 or 5, characterized in that: The aminoglucose 6-position sialyltransferase is obtained by constructing a recombinant expression system; the recombinant expression system is a non-microbial expression system.
7. The enzymatic synthesis method according to any one of claims 3 to 5, characterized in that: After the reaction was completed, thin layer chromatography was used to track the reaction progress, and the developing solvent was ethyl acetate: methanol: water: acetic acid = 4:2:1:0.2 system for detection.
Citation Information
Cited By
Synthesis method of N-acetylglucosamine 6-position sulfated human milk oligosaccharide
CN121204190A
A method for the synthesis of sulfated human milk oligosaccharide at position 6 of n-acetylglucosamine
CN121204190B
Protein useful for production of human milk oligosaccharide dslnt
WO2025205666A1
